MedTrace Logo

Sleep and Stress Study

NCT07315516 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2026-04-23

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if natural supplements (lavender oil, PEA, and OEA) work to improve sleep and reduce stress in adults with moderate stress levels and sleep difficulties. It will also learn about the safety of these natural supplements.

The main questions it aims to answer are:

* Do these supplements improve sleep quality?
* Do they reduce perceived stress levels?
* Do they reduce anxiety symptoms?
* What medical problems do participants have when taking these supplements?

Researchers will compare three active treatment groups (lavender oil, PEA, Trpti which contains OEA) to a placebo (a look-alike capsule that contains no active ingredients) to see if these natural supplements work to improve sleep and reduce stress.

Participants will take 1 capsule (either active supplement or placebo) every day for 8 weeks and attend 2 clinic visits with a phone check in in between.

Conditions

  • Sleep Disorder (Disorder)
  • Stress
  • Anxiety

Interventions

DIETARY_SUPPLEMENT

Lavender Oil

85mg CPO Lavender oil will be administered daily. This will be taken as a capsule, 1 capsule daily for 57 days.

DIETARY_SUPPLEMENT

Palmitoylethanolamide (PEA)

75mg Levagen+ PEA will be administered daily. This will be taken as a capsule, 1 capsule daily for 57 days.

DIETARY_SUPPLEMENT

Oleoylethanolamide

150mg Trpti OEA will be administered daily. This will be taken as a capsule, 1 capsule daily for 57 days

OTHER

Placebo

A placebo capsule containing microcrystalline cellulose will be taken daily, 1 capsule will be taken each day for 57 days.

Sponsors & Collaborators

  • Gencor Pacific Limited, Hong Kong

    collaborator INDUSTRY

  • RDC Clinical Pty Ltd

    lead INDUSTRY

Principal Investigators

  • RV Venkatesh · Gencor Pacific

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-07
Primary Completion
2027-02-28
Completion
2027-02-28

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07315516 on ClinicalTrials.gov